CICC portfolio

CICC has 5 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.

Website: cicc.com.

Type: Private equity.

Portfolio on Recent Funding: 5.

Deals, last 12 months: 1.

Rounds led: 3 of 4.

Capital in their rounds: $154.36M.

Latest deal: Zhishu Technology · Oct 21, 2026.

About this page

It is a private equity firm based in Beijing, CN. It led 3 of the 4 rounds it joined. Its most recent investment on record is Zhishu Technology's $29.96M Series B+ round in October 2026, which it led, alongside Tao Capital, Jiaxin Zhishu, Hongchuang Capital and 3 others. By category, its portfolio leans toward Health and bio (2) and Robotics and hardware (2). It has co-invested with Tao Capital, Jiaxin Zhishu and Hongchuang Capital.

About CICC

Firm type: Private equity.

Headquarters: Beijing, CN.

Stages: Growth, Late Stage.

Sectors: Advanced Manufacturing, Consumer, Crypto & Web3, Healthtech.

The companies CICC bought, as a private equity firm: CICC acquisitions.

What CICC invests in

Health and bio · 2 · 40%
Robotics and hardware · 2 · 40%
Logistics and mobility · 1 · 20%
Manufacturing and industrial · 1 · 20%
AI agents · 1 · 20%
Fintech · 1 · 20%
Education · 1 · 20%

CICC recent investments

Company	Round	Date	Alongside
ZZhishu Technology	Series B+ · $29.96M · lead	Oct 21, 2026	Tao Capital, Jiaxin Zhishu, Hongchuang Capital +3
NNeolix	Series B+ · lead	Feb 19, 2025	Cygnus Equity, Vinno Capital
KKingsware	Series B+ · $72.4M	Mar 3, 2023	China Development Bank Capital (lead), Junsan Capital, Wen's Investment +3
RRgenta Therapeutics	Series A · $52M · lead	Nov 29, 2022	Lilly Asia Ventures, Kaitai Capital, Vivo Capital +6

How CICC invests

Stage	Deals	Capital in rounds
Series B+	3 75%	$102.36M
Series A	1 25%	$52M

Year	Deals	Capital in rounds
2022	1 25%	$52M
2023	1 25%	$72.4M
2025	1 25%	undisclosed
2026	1 25%	$29.96M

CICC portfolio companies

ZZhishu Technology$29.96MSeries B+ · Oct 2026
NNeolixSeries B+ · Feb 2025
KKingsware$72.4MSeries B+ · Mar 2023
RRgenta Therapeutics$52MSeries A · Nov 2022
VValue Simplexbacker

Company	Round with CICC	Total raised	Latest raise
ZZhishu Technology Health and bio	Oct 21, 2026 Series B+ · $29.96M · lead	$29.96M	Oct 21, 2026 Series B+
NNeolix Robotics and hardware	Feb 19, 2025 Series B+ · lead	$428M	Oct 20, 2026 Series B+
KKingsware AI agents	Mar 3, 2023 Series B+ · $72.4M	$72.4M	Mar 3, 2023 Series B+
RRgenta Therapeutics Health and bio	Nov 29, 2022 Series A · $52M · lead	$52M	Nov 29, 2022 Series A
VValue Simplex Fintech	backer	undisclosed	Oct 20, 2026 Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 4 rounds on Recent Funding that name CICC. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists CICC, which is a subset of its real portfolio. API: /api/v1/investors/cicc (get a free API key). More: the most active VC firms and new venture capital funds.